Whilst I have other points to respond to, the trendline of increased AZ usage in France is clear, and with AZ now forecasting even fewer deliveries in April (20mm) than March (30mm) I imagine there will be bigger emphasis on retaining second doses for stockpile to meet 3-4 week second dose. So only utilising 50% could actually be a "realistic" ceiling for the current jab gap (whether the jab gap should be delayed is a another argument) given supply uncertainty.laurent wrote: ↑Mon Mar 15, 2021 10:57 amThe numbers of jabs have doubled I doubt the stock have increased. (when they allowed pharmacist to do the jab the GP had to take a week off... (This lead to a good bit of screaming with appointments having to be cancelled).Saint wrote: ↑Mon Mar 15, 2021 10:28 amSo, the report as of the start of the month was that out of the 1.7 million doses delivered to France by then, 600K had been issued to pharmacies and GPs, only 150K had been used. So it's sitting the the fridges centrally, and sitting in the fridges locally Pfizer in the meantime is flying off the shelves
I think logistics are way to complicated
And here, whilst clunky to read (although can't think of better presentation), we can see that this usage Vs supply rate is unsustainable even with the latest delivery.
The "doses are just going to sit in fridges and not get used" argument does not hold water.